BU-NOT-SET

CONTACT US
The future of oral solid dose development and manufacturing
  • Drug product
  • Industry trends
Products
Insight
Sustainability Report 2021
  • Sustainability
Sustainability report
Report
Treating long-COVID with Erdosteine
  • Corporate
Treating long-COVID with Erdosteine
Insight
Three trends driving small molecule API market growth
  • Drug product
Product
Insight
Vaccine manufacturing
  • Drug product
Vials manufacturing line
Fact sheet
Solving the challenges during oral solid dosage development
  • Drug product
Oral product mix
Insight
mRNA vaccine manufacturing: how to unlock success
  • Drug product
Vaccine in vials
Insight
Pharma packaging trends under the spotlight
  • Manufacturing
Packaging line
Insight
Modified release formulation and manufacture
  • Drug product
Product
Insight
Insight
  • Drug substance
Regulatory requirements for drug substances
Insight
  • Analytical chemistry
The QbD approach: Key advantages in clinical and commercial phases
Report
  • Sustainability
Sustainability report 2020
Poster
  • Drug substance
Recipharm and Oncopeptides: Successful collaboration in the development of melflufen, a peptidase-potentiated alkylating agent in clinical trials
Fact sheet
  • Analytical chemistry
Recipharm Analytical Solutions™
Fact sheet
  • Analytical chemistry
Impurity identification
Fact sheet
  • Analytical chemistry
Stability studies
Fact sheet
  • Analytical chemistry
Extractables & leachables testing
Insight
  • Industry trends
Pharmaceutical mergers and acquisitions: opportunities and drivers for CDMOs